Spontaneous muscle action potentials fail to develop without fetal-type acetylcholine receptors

In mammals, two combinations of muscle nicotinic acetylcholine receptors (AChRs) are used: α2βγδ (γ‐AChR) or α2βϵδ (ϵ‐AChR). After birth, γ‐AChRs are replaced by ϵ‐AChRs (γ/ϵ‐switch). The two receptors have different conductances and open times. During perinatal period, the long open time γ‐AChRs ge...

Full description

Saved in:
Bibliographic Details
Published in:EMBO reports Vol. 3; no. 7; pp. 674 - 681
Main Authors: Takahashi, Masazumi, Kubo, Tai, Mizoguchi, Akira, Carlson, C George, Endo, Katsuaki, Ohnishi, Katsunori
Format: Journal Article
Language:English
Published: Chichester, UK John Wiley & Sons, Ltd 01-07-2002
Blackwell Publishing Ltd
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In mammals, two combinations of muscle nicotinic acetylcholine receptors (AChRs) are used: α2βγδ (γ‐AChR) or α2βϵδ (ϵ‐AChR). After birth, γ‐AChRs are replaced by ϵ‐AChRs (γ/ϵ‐switch). The two receptors have different conductances and open times. During perinatal period, the long open time γ‐AChRs generate random myofiber action potentials from uniquantal miniature end‐plate potentials (mEPPs). ϵ‐AChRs are suitable for strong adult muscle activities. Since the effect of the γ/ϵ‐switch on neuromuscular development was unclear, despite the many differences in channel characteristics, we carried out this study to generate γ‐subunit‐deficient mice. Homozygotes born alive survived for 2 days in a stable condition, and were able to move their forelimbs. Endplate AChRs included ϵ‐subunits, and muscle fibers had multiple neuromuscular junctions. Both pre‐ and postsynapses were abnormal and spontaneous action potentials generated from mEPPs were totally absent. Results suggest a requirement for γ‐AChRs in mediating synaptically‐induced action potential activity critical for neuromuscular development.
Bibliography:istex:DCF32864D9CA0FCB0131427D0D6E31804427315B
ArticleID:EMBR130
ark:/67375/WNG-B4ZTN8SC-R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author at present address: Centre National de Genotypage, 2 rue Gaston Cremieux-CP5721, 91057 Evry Cedex, France. Tel: +33 1 60 87 83 33; Fax: +33 1 60 87 83 83; E-mail: masazumi@cng.fr
Present address: National Institute of Bioscience and Human-Technology, AIST, MITI, 1–1 Higashi, Tsukuba 305-8566, Japan
ISSN:1469-221X
1469-3178
DOI:10.1093/embo-reports/kvf128